DNA methylation and chromatin modifiers in colorectal cancer

. 2019 Oct ; 69 () : 73-92. [epub] 20190430

Jazyk angličtina Země Velká Británie, Anglie Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/pmid31028771
Odkazy

PubMed 31028771
DOI 10.1016/j.mam.2019.04.002
PII: S0098-2997(19)30008-1
Knihovny.cz E-zdroje

Colorectal carcinogenesis is a multistep process involving the accumulation of genetic alterations over time that ultimately leads to disease progression and metastasis. Binding of transcription factors to gene promoter regions alone cannot explain the complex regulation pattern of gene expression during this process. It is the chromatin structure that allows for a high grade of regulatory flexibility for gene expression. Posttranslational modifications on histone proteins such as acetylation, methylation, or phosphorylation determine the accessibility of transcription factors to DNA. DNA methylation, a chemical modification of DNA that modulates chromatin structure and gene transcription acts in concert with these chromatin conformation alterations. Another epigenetic mechanism regulating gene expression is represented by small non-coding RNAs. Only very recently epigenetic alterations have been included in molecular subtype classification of colorectal cancer (CRC). In this chapter, we will provide examples of the different epigenetic players, focus on their role for epithelial-mesenchymal transition and metastatic processes and discuss their prognostic value in CRC.

Citace poskytuje Crossref.org

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

Methylation-Based Therapies for Colorectal Cancer

. 2020 Jun 24 ; 9 (6) : . [epub] 20200624

Colorectal Adenomas-Genetics and Searching for New Molecular Screening Biomarkers

. 2020 May 05 ; 21 (9) : . [epub] 20200505

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...